These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18433972)

  • 1. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells.
    Jeurissen SM; Punt A; Delatour T; Rietjens IM
    Food Chem Toxicol; 2008 Jun; 46(6):2296-302. PubMed ID: 18433972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem mass spectrometry analysis of N2-(trans-Isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole.
    Punt A; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
    Chem Res Toxicol; 2007 Jul; 20(7):991-8. PubMed ID: 17590023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
    Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix-derived combination effect and risk assessment for estragole from basil-containing plant food supplements (PFS).
    van den Berg SJ; Klaus V; Alhusainy W; Rietjens IM
    Food Chem Toxicol; 2013 Dec; 62():32-40. PubMed ID: 23959103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
    Alhusainy W; Paini A; van den Berg JH; Punt A; Scholz G; Schilter B; van Bladeren PJ; Taylor S; Adams TB; Rietjens IM
    Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1'-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism.
    Probert PM; Palmer JM; Alhusainy W; Amer AO; Rietjens IM; White SA; Jones DE; Wright MC
    Toxicol Lett; 2016 Jan; 243():98-110. PubMed ID: 26739637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
    Al-Subeihi AA; Alhusainy W; Paini A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Food Chem Toxicol; 2013 Sep; 59():564-71. PubMed ID: 23831728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1'-hydroxy-2',3'-dehydroestragole in infant male C57BL/6J x C3H/HeJ F1 mice.
    Fennell TR; Wiseman RW; Miller JA; Miller EC
    Cancer Res; 1985 Nov; 45(11 Pt 1):5310-20. PubMed ID: 3863702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1'-hydroxysafrole and 1'-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues.
    Wiseman RW; Fennell TR; Miller JA; Miller EC
    Cancer Res; 1985 Jul; 45(7):3096-105. PubMed ID: 4005847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
    Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular levels and molecular dynamics simulations of estragole DNA adducts point at inefficient repair resulting from limited distortion of the double-stranded DNA helix.
    Yang S; Diem M; Liu JDH; Wesseling S; Vervoort J; Oostenbrink C; Rietjens IMCM
    Arch Toxicol; 2020 Apr; 94(4):1349-1365. PubMed ID: 32185416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical identification of hepatic protein adducts derived from estragole.
    Wakazono H; Gardner I; Eliasson E; Coughtrie MW; Kenna JG; Caldwell J
    Chem Res Toxicol; 1998 Aug; 11(8):863-72. PubMed ID: 9705747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling.
    Paini A; Punt A; Scholz G; Gremaud E; Spenkelink B; Alink G; Schilter B; van Bladeren PJ; Rietjens IM
    Mutagenesis; 2012 Nov; 27(6):653-63. PubMed ID: 22844077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
    Paini A; Punt A; Viton F; Scholz G; Delatour T; Marin-Kuan M; Schilter B; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2010 May; 245(1):57-66. PubMed ID: 20144636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix modulation of the bioactivation of estragole by constituents of different alkenylbenzene-containing herbs and spices and physiologically based biokinetic modeling of possible in vivo effects.
    Alhusainy W; van den Berg SJ; Paini A; Campana A; Asselman M; Spenkelink A; Punt A; Scholz G; Schilter B; Adams TB; van Bladeren PJ; Rietjens IM
    Toxicol Sci; 2012 Sep; 129(1):174-87. PubMed ID: 22649189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat.
    Alhusainy W; Williams GM; Jeffrey AM; Iatropoulos MJ; Taylor S; Adams TB; Rietjens IM
    Food Chem Toxicol; 2014 Dec; 74():28-34. PubMed ID: 25218219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling.
    Punt A; Jeurissen SM; Boersma MG; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
    Toxicol Sci; 2010 Feb; 113(2):337-48. PubMed ID: 19920071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of specific DNA adducts by liquid chromatography-tandem mass spectrometry in the livers of rats given estragole at the carcinogenic dose.
    Ishii Y; Suzuki Y; Hibi D; Jin M; Fukuhara K; Umemura T; Nishikawa A
    Chem Res Toxicol; 2011 Apr; 24(4):532-41. PubMed ID: 21384859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats.
    Punt A; Paini A; Boersma MG; Freidig AP; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
    Toxicol Sci; 2009 Aug; 110(2):255-69. PubMed ID: 19447879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemomodulatory efficacy of basil leaf (Ocimum basilicum) on drug metabolizing and antioxidant enzymes, and on carcinogen-induced skin and forestomach papillomagenesis.
    Dasgupta T; Rao AR; Yadava PK
    Phytomedicine; 2004 Feb; 11(2-3):139-51. PubMed ID: 15070164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.